Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
1.
Rev Med Suisse ; 7(292): 905-10, 2011 Apr 27.
Artículo en Francés | MEDLINE | ID: mdl-21674894

RESUMEN

Controversies regarding the pathogenesis of cardiovascular diseases in HIV patients Since the introduction of HAART (Highly active anti-retroviral therapy), the incidence of cardiovascular events has risen in patients infected with HIV. This development is mainly due to the increased survival in these patients. Nonetheless, the pathogenic effects of HIV on the principal components of haemostasis (endothelium, platelets and the clotting cascade) are the subject of numerous ongoing research studies, and are becoming an argument for starting HAART or for modifying the components of an established therapy. The aim of this article is to raise clinician awareness regarding the issue of cardiovascular disease in the HIV-infected patient.


Asunto(s)
Enfermedades Cardiovasculares/fisiopatología , Infecciones por VIH/fisiopatología , Endotelio Vascular/fisiopatología , Humanos
2.
Rev Med Suisse ; 3(97): 336-8, 340, 2007 Feb 07.
Artículo en Francés | MEDLINE | ID: mdl-17370731

RESUMEN

Peripheral artery disease (PAD) is frequently overlooked because of its silent evolution for quite a long period and because it has not been considered as harmful as other atherothrombosis complications such as myocardial infarction or stroke. PAD is readily diagnosed by measuring the ankle brachial index (ABI). A reduced ABI is able to identify an asymptomatic PAD in a high risk patient and provides a very valuable predictor of cardiovascular events allowing to better profile the individual risk of the patient. The awareness of PAD as a mark of a generalized atherothrombosis disease holds the potential to increase the doctor's view of the true individual risk of his patient and to enforce cardiovascular risk prevention as suggested by recent studies.


Asunto(s)
Tobillo/irrigación sanguínea , Aterosclerosis/diagnóstico , Presión Sanguínea , Arteria Braquial , Medicina Familiar y Comunitaria , Enfermedades Vasculares Periféricas/diagnóstico , Brazo , Aterosclerosis/fisiopatología , Enfermedades Cardiovasculares/prevención & control , Humanos , Claudicación Intermitente/diagnóstico , Tamizaje Masivo , Enfermedades Vasculares Periféricas/fisiopatología
3.
J Psychiatr Ment Health Nurs ; 24(1): 41-56, 2017 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-27928857

RESUMEN

WHAT IS KNOWN ON THE SUBJECT?: When mental health professionals leave organizations, detrimental effects on quality of patient care occur. Reasons for leaving include incivility, lack of autonomy, perceptions of unfair treatment and feeling psychologically unsafe at work. This paper sought to investigate additional reasons why mental health professionals intend to quit or to cognitively withdraw from their jobs. WHAT DOES THIS PAPER ADD TO EXISTING KNOWLEDGE?: Past research on this topic is limited in its scope and data. Mainly fragmented evidence is available about predictors of job satisfaction and turnover intention (i.e. different mental health occupations examined in separate studies). Only two existing studies that examined broader mental health provider groups were limited by including few workforce settings, small sample sizes and insufficiently rigorous statistical analyses. We examined four occupations (mental health nurses, social workers, psychologists and psychiatrists), each represented through a large sample in multiple settings, all within one large healthcare network with complex patients. Our contribution is finding additional predictors (supervisory support, emotional exhaustion) of job satisfaction/turnover intention. WHAT ARE THE IMPLICATIONS FOR PRACTICE?: Organizations can consider using culture change initiatives to increase civility at work; this includes leadership support and role modelling of workplace behaviours. Leaders should monitor staffing levels and high workloads to pre-empt emotional exhaustion, which predicts turnover. Hiring and training supervisors should involve not only technical expertise, but also 'soft skills' necessary for creating civil and supportive work environments. Leaders and managers should use employee feedback data (e.g. organizational surveys) to learn about the workplace environments, and address areas of employees' concern. ABSTRACT: Introduction Given the global shortage of mental health professionals, high turnover rates within this workforce are concerning. We used United States of America Veterans Health Administration data to add to the limited knowledge about this topic. Aim We examined predictors of turnover intention, or an employee's cognitive withdrawal from their job, in a large sample of direct care mental health professionals, separating among occupations to increase the pragmatic relevance of our findings. Method Survey data from 10 997 mental health employees working in direct patient contact (2432 registered nurses, 3769 social workers, 2520 psychologists and 1276 psychiatrists) were used in a cross-sectional design with structural equation modelling techniques for model testing. Results Job satisfaction was predicted by civility (courteous and respectful workplace behaviours) and supervisory support. Job satisfaction predicted emotional exhaustion which predicted turnover intention. Job satisfaction also directly predicted turnover intention and turnover plans. Discussion Predictors of job satisfaction included civility and supervisory support. Emotional exhaustion predicted turnover intention. Results inform organizational actions to address these work environment characteristics. Implications for practice Organizations can initiate culture changes to improve civility and develop supervisors' 'soft skills' in conjunction with technical expertise.


Asunto(s)
Personal de Salud/psicología , Satisfacción en el Trabajo , Fatiga Mental/psicología , Servicios de Salud Mental/estadística & datos numéricos , Administración de Personal/estadística & datos numéricos , Reorganización del Personal/estadística & datos numéricos , Adulto , Femenino , Humanos , Intención , Masculino , Persona de Mediana Edad , Enfermería Psiquiátrica/estadística & datos numéricos , Psiquiatría/estadística & datos numéricos , Psicología Clínica/estadística & datos numéricos , Trabajadores Sociales/estadística & datos numéricos , Adulto Joven
4.
J Thromb Haemost ; 15(7): 1351-1360, 2017 07.
Artículo en Inglés | MEDLINE | ID: mdl-28440041

RESUMEN

Essentials Acute iliofemoral deep vein thrombosis can be treated with catheter-directed thrombolysis (CDT). We performed a randomized trial comparing conventional CDT versus ultrasound-assisted CDT (USAT). Clinical and duplex sonographic outcomes at 12 months were similar in the CDT and USAT groups. In both groups, incidence of postthrombotic syndrome was very low with good quality of life. SUMMARY: Background In patients with acute iliofemoral deep vein thrombosis (IFDVT), catheter-directed thrombolysis (CDT) aims to prevent the postthrombotic syndrome (PTS). Adding intravascular high-frequency, low-power ultrasound energy to CDT does not seem to improve the immediate thrombolysis results but its impact on clinical outcomes at 12 months is not known. Patients/Methods In this randomized-controlled trial, 48 patients (mean age 50 ± 21 years; 52% women) with acute IFDVT were randomized to conventional CDT (n = 24) or ultrasound-assisted CDT (USAT; n = 24). In both groups, a fixed-dose thrombolysis regimen (20 mg r-tPA over 15 h) was used, followed by routine stenting of residual venous obstruction. At 12 months, PTS and venous disease severity (Villalta score and revised Venous Clinical Severity Score [rVCSS]), disease-specific quality of live (QOL; CIVIQ-20) and duplex-sonographic outcomes were assessed. Results Among the 45 surviving patients, 40 (89%; 95% confidence interval [CI] 76-96%) patients were free from PTS (defined as Villalta score < 5 points; 83%, 95% CI 61-95% in the USAT and 96%, 95% CI 77-100% in the CDT group), with a similar mean total Villalta score of 2.3 ± 2.9 vs. 1.7 ± 1.6, and a mean total rVCSS of 3.0 ± 3.5 vs. 2.7 ± 2.9 in the USAT and the CDT groups, respectively. Both groups had good disease-specific QOL with a CIVIQ-20 score of 29.4 ± 11.8 vs. 26.1 ± 7.8, respectively. Primary (100% vs. 92%) and secondary (100% vs. 96%) iliofemoral patency rates and presence of femoro-popliteal venous reflux (39% vs. 33%) were similar in both groups. Conclusion The addition of intravascular ultrasound energy to conventional CDT for the treatment of acute IFDVT did not have any impact on relevant clinical or duplex sonographic outcomes, which were favorable in both study groups. Clinical Trial Registration URL: http://www.clinicaltrials.gov. Unique identifier:NCT01482273.


Asunto(s)
Vena Femoral/fisiopatología , Síndrome Postrombótico/prevención & control , Síndrome Postrombótico/psicología , Terapia Trombolítica/efectos adversos , Terapia Trombolítica/métodos , Ultrasonografía , Trombosis de la Vena/fisiopatología , Trombosis de la Vena/terapia , Adolescente , Adulto , Anciano , Anticoagulantes/uso terapéutico , Cateterismo , Femenino , Estudios de Seguimiento , Humanos , Masculino , Persona de Mediana Edad , Calidad de Vida , Recurrencia , Factores de Tiempo , Resultado del Tratamiento , Adulto Joven
5.
Rev Med Suisse ; 2(51): 318-22, 2006 Feb 01.
Artículo en Francés | MEDLINE | ID: mdl-16512002

RESUMEN

Deep vein thrombosis in children and adolescents is a quite rare event. Risk factors most often associated with DVT in this particular population are: central vein catheters, neoplasia, vascular malformations and oral contraception. Diagnosis and management of DVT in adolescents does not differ greatly from that of adults. Compression ultrasound is the initial exam of choice. Hospitalization is often not necessary and treatment can be started by using low molecular weight heparin followed by oral anti-vitamin K antagonists. Thrombophilia screening is not routinely recommended and should be reserved for those patients for whom results would change therapeutical management.


Asunto(s)
Tromboembolia/etiología , Tromboembolia/terapia , Adolescente , Humanos , Factores de Riesgo , Tromboembolia/diagnóstico , Tromboembolia/epidemiología
6.
Circulation ; 100(7): 700-5, 1999 Aug 17.
Artículo en Inglés | MEDLINE | ID: mdl-10449690

RESUMEN

BACKGROUND: Administration of protease inhibitors (PIs) to HIV-infected individuals has been associated with hyperlipidemia. In this study, we characterized the lipoprotein profile in subjects receiving ritonavir, indinavir, or nelfinavir, alone or in combination with saquinavir. METHODS AND RESULTS: Plasma lipoprotein levels were quantified in 93 HIV-infected adults receiving PIs. Comparison was done with pretreatment values and with 28 nonPI-treated HIV-infected subjects. An elevation in plasma cholesterol levels was observed in all PI-treated groups but was more pronounced for ritonavir (2.0+/-0.3 mmol/L [mean+/-SEM], n=46, versus 0.1+/-0.2 mmol/L in nonPI treated group, P<0.001) than for indinavir (0.8+/-0.2 mmol/L, n=26, P=0.03) or nelfinavir (1.2+/-0.2 mmol/L, n=21, P=0.01). Administration of ritonavir, but not indinavir or nelfinavir, was associated with a marked elevation in plasma triglyceride levels (1.83+/-0.46 mmol/L, P=0.002). Plasma HDL-cholesterol levels remained unchanged. Combination of ritonavir or nelfinavir with saquinavir did not further elevate plasma lipid levels. A 48% increase in plasma levels of lipoprotein(a) was detected in PI-treated subjects with pretreatment Lp(a) values >20 mg/dL. Similar changes in plasma lipid levels were observed in 6 children receiving ritonavir. CONCLUSIONS: Administration of PIs to HIV-infected individuals is associated with a marked, compound-specific dyslipidemia. The risk of pancreatitis and premature atherosclerosis due to PI-associated dyslipidemia remains to be established.


Asunto(s)
Fármacos Anti-VIH/efectos adversos , Arteriosclerosis/etiología , Infecciones por VIH/tratamiento farmacológico , Inhibidores de la Proteasa del VIH/efectos adversos , Hiperlipidemias/inducido químicamente , Lipoproteínas/sangre , Adulto , Fármacos Anti-VIH/administración & dosificación , Fármacos Anti-VIH/uso terapéutico , Niño , Quimioterapia Combinada , Femenino , Infecciones por VIH/sangre , Inhibidores de la Proteasa del VIH/administración & dosificación , Inhibidores de la Proteasa del VIH/uso terapéutico , Humanos , Hipercolesterolemia/inducido químicamente , Hipercolesterolemia/epidemiología , Hiperlipidemias/sangre , Hiperlipidemias/complicaciones , Hiperlipidemias/epidemiología , Hipertrigliceridemia/inducido químicamente , Hipertrigliceridemia/epidemiología , Indinavir/administración & dosificación , Indinavir/efectos adversos , Indinavir/uso terapéutico , Lípidos/sangre , Lipoproteína(a)/sangre , Modelos Logísticos , Masculino , Nelfinavir/administración & dosificación , Nelfinavir/efectos adversos , Nelfinavir/uso terapéutico , Factores de Riesgo , Ritonavir/administración & dosificación , Ritonavir/efectos adversos , Ritonavir/uso terapéutico , Saquinavir/administración & dosificación , Saquinavir/efectos adversos , Saquinavir/uso terapéutico , Tirotropina/sangre
7.
Cardiovasc Intervent Radiol ; 31 Suppl 2: S53-6, 2008 Jul.
Artículo en Inglés | MEDLINE | ID: mdl-18172713

RESUMEN

Delayed stent fracture has been observed in many different arteries and may represent a risk factor for restenosis. We describe the case of a delayed rupture of an endovascular brachiocephalic trunk stent. The complete fracture allowed a fragment to migrate distally and tilt, resulting in a hemodynamic pattern similar to that of a prevertebral stenosis with complete inversion of the homolateral vertebral blood flow. The induced vertebral steal syndrome as well as the risk of cerebral embolism was corrected by an aortobrachiocephalic bypass and resection of the ruptured stent.


Asunto(s)
Tronco Braquiocefálico , Migración de Cuerpo Extraño/complicaciones , Migración de Cuerpo Extraño/diagnóstico por imagen , Stents/efectos adversos , Síndrome del Robo de la Subclavia/diagnóstico por imagen , Síndrome del Robo de la Subclavia/etiología , Angiografía , Migración de Cuerpo Extraño/cirugía , Humanos , Masculino , Persona de Mediana Edad , Radiografía Intervencional , Rotura , Síndrome del Robo de la Subclavia/cirugía , Toracotomía , Tomografía Computarizada por Rayos X
8.
J Thromb Haemost ; 6(8): 1281-8, 2008 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-18541001

RESUMEN

INTRODUCTION: Intravenous (i.v.) therapy may be associated with important catheter-related morbidity and discomfort. The safety, efficacy, comfort, and cost-effectiveness of peripherally inserted central catheters (PICCs) were compared to peripheral catheters (PCs) in a randomized controlled trial. METHODS: Hospitalized patients requiring i.v. therapy >or= five days were randomized 1:1 to PICC or PC. Outcomes were incidence of major complications, minor complications, efficacy of catheters, patient satisfaction, and cost-effectiveness. RESULTS: 60 patients were included. Major complications were observed in 22.6% of patients in the PICC group [six deep venous thrombosis (DVT), one insertion-site infection] and 3.4% of patients in the PC group [one DVT; risk ratio (RR) 6.6; P = 0.03]. Superficial venous thrombosis (SVT) occurred in 29.0% of patients in the PICC group and 37.9% of patients in the PC group (RR 0.60; P = 0.20). Patients in the PICC group required 1.16 catheters on average during the study period, compared with 1.97 in the PC group (P < 0.04). The mean number of venipunctures (catheter insertion and blood sampling) was 1.36 in the PICC group vs. 8.25 in the PC group (P < 0.001). Intravenous drug administration was considered very or quite satisfying by 96.8% of the patients in the PICC group, and 79.3% in the PC group. Insertion and maintenance mean cost was 690 US$ for PICC and 237 US$ for PC. DISCUSSION: PICC is efficient and satisfying for hospitalized patients requiring i.v. therapy >or= five days. However, the risk of DVT, mostly asymptomatic, appears higher than previously reported, and should be considered before using a PICC.


Asunto(s)
Cateterismo Venoso Central , Cateterismo Periférico , Anciano , Anciano de 80 o más Años , Cateterismo Venoso Central/efectos adversos , Cateterismo Venoso Central/economía , Cateterismo Periférico/efectos adversos , Cateterismo Periférico/economía , Análisis Costo-Beneficio , Femenino , Hospitalización , Humanos , Infecciones/etiología , Masculino , Persona de Mediana Edad , Satisfacción del Paciente , Seguridad , Factores de Tiempo , Resultado del Tratamiento , Trombosis de la Vena/etiología
9.
Praxis (Bern 1994) ; 95(24): 977-81, 2006 Jun 14.
Artículo en Francés | MEDLINE | ID: mdl-16802507

RESUMEN

Systemic amyloidosis with cardiac involvement may clinically be suspected in the presence of heart failure or arrhythmia of unknown origin. Herein two cases of cardiac amyloidosis are described with a clinical presentation of heart failure refractory to usual treatment. The key role of echocardiography in the diagnosis and prognosis evaluation of cardiac amyloidosis is discussed. A treatment targeted against the generation of amyloid fibril should ideally be initiated before apparition of heart failure.


Asunto(s)
Amiloidosis/diagnóstico por imagen , Cardiomiopatías/diagnóstico por imagen , Ecocardiografía , Anciano , Amiloidosis/patología , Amiloidosis/terapia , Biopsia , Cardiomiopatías/patología , Cardiomiopatías/terapia , Diagnóstico Diferencial , Electrocardiografía , Resultado Fatal , Insuficiencia Cardíaca/diagnóstico por imagen , Insuficiencia Cardíaca/patología , Insuficiencia Cardíaca/terapia , Humanos , Persona de Mediana Edad , Pronóstico , Tejido Subcutáneo/patología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA